Nisa Investment Advisors
MCRB icon

Nisa Investment Advisors’s Seres Therapeutics MCRB Stock Holding History

Nisa Investment Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$140 – 3073
2025
Q1 		$140 Sell
10
-5
-33% -$78 ﹤0.01% 2949
2024
Q4 		$256 Hold
15
– – ﹤0.01% 2914
2024
Q3 		$291 Hold
15
– – ﹤0.01% 2804
2024
Q2 		$223 Buy
15
+10
+200% +$167 ﹤0.01% 2800
2024
Q1 		$84 Buy
+5
New +$108 ﹤0.01% 2724
2023
Q4 		– Sell
-131
Closed -$6.24K – 2700
2023
Q3 		$6.24K Sell
131
-3
-2% -$229 ﹤0.01% 2261
2023
Q2 		$12.8K Buy
134
+104
+347% +$11.3K ﹤0.01% 2215
2023
Q1 		$3K Hold
30
– – ﹤0.01% 2287
2022
Q4 		$3K Hold
30
– – ﹤0.01% 2342
2022
Q3 		$5K Hold
30
– – ﹤0.01% 2292
2022
Q2 		$2K Hold
30
– – ﹤0.01% 2346
2022
Q1 		$4K Sell
30
-265
-90% -$40.8K ﹤0.01% 2323
2021
Q4 		$49K Buy
295
+265
+883% +$42.1K ﹤0.01% 1741
2021
Q3 		$4 Sell
30
-165
-85% -$32.3K ﹤0.01% 2272
2021
Q2 		$93 Buy
195
+165
+550% +$69.6K ﹤0.01% 1731
2021
Q1 		$12 Sell
30
-97
-76% -$44.7K ﹤0.01% 2188
2020
Q4 		$62K Sell
127
-15
-11% -$8.78K ﹤0.01% 1929
2020
Q3 		$80K Buy
142
+92
+184% +$30.6K ﹤0.01% 1612
2020
Q2 		$5K Hold
50
– – ﹤0.01% 2008
2020
Q1 		$4K Buy
+50
New +$3.35K ﹤0.01% 1976
2017
Q4 		– Sell
-210
Closed -$67K – 1846
2017
Q3 		$67K Hold
210
– – ﹤0.01% 1424
2017
Q2 		$50K Buy
+210
New +$43.1K ﹤0.01% 1406

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Nisa Investment Advisors's MCRB Position: Q2 2025 in Review

Nisa Investment Advisors sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 10 shares — an estimated $140 sold.

Nisa Investment Advisors first reported a position in MCRB in Q2 2017 and held it in 22 quarters. The position peaked at $80K in Q3 2020. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Nisa Investment Advisors reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 10 Seres Therapeutics shares in Q2 2025, an estimated $140.
  • Nisa Investment Advisors first reported a position in Seres Therapeutics in Q2 2017 and held it in 22 quarters.
  • Nisa Investment Advisors's Seres Therapeutics position peaked at $80K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.